TranScrip Medical Affairs

TranScrip have a wide range of experience and expertise in supporting products at launch and during life-cycle management and can support a variety of medical affairs activities, including phase IV studies, development of advocacy and communication strategies or promotional materials.


TranScrip Medical Affairs Experts

TranScrip's Medical Affairs team has a wealth of expertise in pre- and post-launch activities across a number of different therapeutic areas. TranScrip has supported development of launch strategies, preparation and execution of publication plans, therapeutic area and product trainings, design of phase IV clinical programmes, various medical information activities and many other aspects of medical affairs.

Tim Joslin
Head of Medical Affairs

Tim leads the Medical Affairs functional team within Transcrip and brings a commercially astute approach to scientific engagement activities.

Tim has a broad range of medical affairs project experience from working across many different therapy areas in both large and medium pharma. Tim’s experience focuses across the whole product life-cycle from pre-clinical to patent expiry, utilising relevant scientific evidence for each product based on the target audience – e.g. clinical trial investigators, treating physicians, payers and other stakeholders. Projects include National, Regional and Global activities covering translational medicine, pre-launch, launch and post-marketing activities. 

Louise Whitley
Deputy Head of Medical Affairs

Louise is one of TranScrip’s senior medical affairs and pharmacovigilance scientists with particular experience in post-authorization referral procedures and label updates.

Louise is involved in many of TranScrip’s pre and post-licensing projects across all therapeutic areas. She has over 20 years of industry experience and has worked for companies such as Lederle Laboratories, Wyeth and Parke Davis.

Louise has extensive experience of medical affairs, pharmacovigilance, medical and regulatory writing, medical information and staff training. She has provided training and mentoring for medical staff and sales representatives. Her product launch experience includes lansoprazole (Zoton), venlafaxine (Efexor) and atorvastatin (Lipitor).

In addition to her industry experience, Louise spent two years as a senior editor of the British National Formulary (BNF) where she was responsible for chapters on the cardiovascular system, vaccines, malignant disease and immunosuppression. She continued to work for the BNF on a variety of projects over subsequent years. Prior to joining the pharmaceutical industry, Louise worked as a clinical pharmacist for the NHS and she has since worked in a regional drug information centre and as a practice pharmacist developing clinical treatment guidelines and conducting prescribing audits.

Key areas of expertise
1. Medical affairs
2. Pharmacovigilance
3. Cross-functional post-licensing support

Case Study

This case study outlines TranScrip’s role in providing a Medical Affairs team to provide support at launch and beyond.​


A pharma company in-licensed a new product in the final stages of regulatory approval but had no medical affairs team to support product launch.


TranScrip Partners assembled a team comprising a medical affairs physician supported by a medical information specialist, a medical writer and a project manager to support peri-launch activities.


The product was launched as planned and a phase IV clinical trial programme was designed and initiated.

TranScrip Partners provide Medical Affairs support across various therapeutic areas to include:

Development of medico-marketing strategies

Design of post-approval interventional & observational studies

Medical input into promotional/training materials

Medical information activities

Preparation of symposia, advisory boards, etc.

Development of publication plans and publication writing

Therapeutic area training

Complete virtual launch